The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells is a paramount challenge with the biopharmaceutical industry. A variety of strategies have been employed maximize antibody titer, such as process parameter optimization, cell line development, and the use of perfusion systems. Fine-tuning culture conditions